GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/13/12/1853/347635/mdf316.pdf
Reference29 articles.
1. Chemotherapy in non-small cell lung cancer using updated data on individual patients from 52 randomised clinical trials;Non-Small Cell Lung Cancer Collaborative Group;Br Med J,1995
2. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small-cell lung cancer: a randomized trial;Depierre;Ann Oncol,1994
3. Randomized study of Navelbine® and cisplatin versus vindesine and cisplatin versus Navelbine® alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients;Le Chevalier;J Clin Oncol,1994
4. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: a Southwest Oncology Group Study;Wozniak;J Clin Oncol,1998
5. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group Trial;Kelly;J Clin Oncol,2001
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chemotherapy for Advanced Non-small Cell Lung Cancer;Cancer Treatment and Research;2016
2. Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer;Cancer Chemotherapy and Pharmacology;2015-05-30
3. Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01);Clinical Lung Cancer;2014-07
4. Early-stage non-small-cell lung cancer: overview of adjuvant chemotherapy and promising advances;Lung Cancer Management;2014-02
5. Comparison of Vinorelbine, Ifosfamide and Cisplatin (NIP) and Etoposide and Cisplatin (EP) for Treatment of Advanced Combined Small Cell Lung Cancer (cSCLC) Patients: A Retrospective Study;Asian Pacific Journal of Cancer Prevention;2012-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3